A detailed history of Maryland State Retirement & Pension System transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Maryland State Retirement & Pension System holds 35,970 shares of CTKB stock, worth $232,366. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,970
Previous 33,412 7.66%
Holding current value
$232,366
Previous $186,000 6.99%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.73 - $6.73 $12,099 - $17,215
2,558 Added 7.66%
35,970 $199,000
Q2 2024

Jul 30, 2024

SELL
$5.3 - $6.91 $13,515 - $17,620
-2,550 Reduced 7.09%
33,412 $186,000
Q4 2023

Feb 06, 2024

SELL
$4.1 - $9.51 $2,865 - $6,647
-699 Reduced 1.91%
35,962 $327,000
Q3 2023

Oct 23, 2023

BUY
$5.52 - $9.5 $30,227 - $52,022
5,476 Added 17.56%
36,661 $202,000
Q2 2023

Jul 10, 2023

BUY
$6.69 - $11.99 $208,627 - $373,908
31,185 New
31,185 $266,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $870M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Maryland State Retirement & Pension System Portfolio

Follow Maryland State Retirement & Pension System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.